Varium™ Wins Best New Poultry Product Middle East at AgraME Awards
Dubai, UAE—The new non‐antibiotic growth promoter Varium™ was named Best New Poultry Product, Middle East at the AgraME Awards on March 14, 2016 at the Dubai International Convention and Exhibition Centre.
Varium is an innovative formulated feed additive that has been shown in clinical studies to promote growth in poultry equivalent to commonly used antiobiotics. It works by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, stimulating early immune function, and strengthening the intestinal barrier function.
Acording to AgraME organizers, the award for Best New Product recognizes an exciting new poultry product that “demonstrates a prominent and far‐reaching competitive advantage, meets market needs through demand focus and offers improvements in cost efficiency.” All entered products were scored against key criteria surrounding leadership, features, innovation, performance, benefits, value and sustainability.
Produced by Amlan International, a leader in improving intestinal health in livestock, Varium has been shown to promote broiler growth equivalent to AGPs by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, strengthening the intestinal barrier function, and stimulating early immune function.
“We’re thrilled that Varium is being recognized for its potential as an AGP replacement and ability to enhance gut health and bird performance,” said Dr. Ron Cravens, President, Amlan International. “In clinical trials, Varium provided a 3:1 return on investment by improving feed conversion and reducing mortality. It also reduced the severity of Clostridium perfringens‐induced necrotic enteritis lesions, providing clear evidence of favorably impacting intestinal health and function.”
More information on Varium can be found at www.Amlan.com and a complete list of AgraME award winners can be found at http://www.agramiddleeast.com.
Amlan International, a division of Oil‐Dri Corporation of America (NYSE: ODC), helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP‐alternative market, driven largely by the research overseen by its laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of China operations in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.